Health Economics for Medical Devices

Addressing Payer Concerns with a Successful Value Proposition

Health Economics for Medical Devices

$995.00

Understand how health economics and outcomes research teams can best support Class II and Class III medical devices throughout their lifecycles.

  • Better understand the competitive landscape and marketplace whenmaking HEOR study decisions.
  • Structure medical device HEOR groups to meet payer requirements for information.
  • Allocate budgets and resources effectively for HEOR studies.
  • Description
  • Additional information

REPORT HIGHLIGHTS

Medical device companies face challenges different from the pharmaceutical industry, thanks to their product lifecycle and their product portfolio complexity. This report will show device companies how HEOR teams can best support Class II and Class III medical devices throughout their lifecycle. Health economics functions can also bolster the profile of existing or updated products by understanding where they fall in the treatment pathway. HEOR groups in different markets will face varying challenges, and this report addresses many of these perspectives.

Health Economics for Medical Devices: Addressing Payer Concerns with a Successful Value Proposition

  • Publication Date: April 2014
  • Pages: 63
  • Chapters: 3
  • Metrics: 400+
  • Charts/Graphics: 40+

Data has also been split by group type:

  • Global
  • Country Level

Data have also been split by launch region:

  • US
  • EU
  • Canada
  • Emerging Markets

Metrics include real-company examples and case studies showing device HEOR group structures, benchmarks and best practices for staffing HEOR groups and outsourcing activities and compensation data for HEOR positions across different levels of experience.

Report Features

This report shows the costs and durations of different types of HEOR studies that medical device companies regularly conduct to best achieve product reimbursement. The best practices included in the study will demonstrate how device company executives get the most out of HEOR teams to drive optimal reimbursement strategy. It also covers the number of each type of study that surveyed companies conduct each year, from 2012 through 2014. This data analysis examines the many different reasons — ranging from cost to marketplace drivers to payers — that cause companies to choose one HEOR study over another. Learn how to achieve group alignment, develop more experienced health economics groups and what activities should be performed by HEOR teams.

Reason To Buy

Medical device companies increasingly use outsourcing to fill knowledge gaps as well as to meet market needs. This study reveals the importance of tailoring outsourcing activities to match payer requirements in terms of clinical trial data or market research. Through examining device companies’ outsourcing practices and approaches to balancing in-house activities and third-party vendors, our analysts were able to analyze and give key outsourcing recommendations. Specifically, this section of the report will help your team understand competition and alternative treatments when determining appropriate HEOR outsourcing spend.

Target Audience

Medical device executives from the following departments will find this study to be very helpful when making strategic decisions:
– Health economics
– Outcomes research
– Payer management
– Payer relations
– Market access
– Government affairs
– Managed markets

Chapter Example

Medical device companies in today’s austerity-driven marketplace encounter a number of challenges. As these companies generally comprise a substantial portion of healthcare provider and hospital budgets, they are easy targets for cost-cutting measures. Device companies must understand each payer’s needs and be prepared to make extensive and evidence-based justifications for each product in their portfolio.

As a result of their product portfolio’s complexity and a different type of product life-cycle, medical device companies face challenges that are different from the conventional pharmaceutical industry. Companies need to be well prepared for payer demands in terms of improving payers’ understanding of these medical devices’ technical aspects.